Qihan's QT-019B program is supported by IND clearance for rSLE from both the US FDA and the China NMPA. The FDA has also granted Fast Track Designation for the SLE-ITP indication. Phase 1 enrollment ...

Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients ...

Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a ...

Research presented at the 2025 ASH Annual Meeting sheds light on serious side effects that appear weeks or months after CAR T cell therapy for multiple myeloma.

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, ...

Discover 40 soothing wellness gifts for people with OCD. See therapist-recommended mindfulness gifts that go beyond the ...

Presented in an oral session at the 67th American Society of Hematology Annual Meeting & Exposition ...

Cogent Biosciences Inc. (NASDAQ:COGT) surged 12.6% in Monday’s premarket session after unveiling encouraging top-line ...

The FMI report, “Carboxy Therapy Market Size, Share, and Forecast 2025–2035,” indicates global revenues will grow by over USD 309 million over the decade, propelled by technological advancements in ...

The Multisystemic Therapy program provides 24/7 therapy to at-risk youth, improving outcomes and reducing re-arrests.

When pressure rises, broad guidance is useless. Teams need a repeatable sequence they can follow when deadlines compress or ...

Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as a mainstay of treatment for individuals living with blood ...